2 unchanged sentences
to Rule 10b5-1 of the Exchange Act or otherwise.
−Removed: During the nine months ended September 30, 2025, none of our directors or officers adopted
+Added: During the three months ended March 31, 2026, none of our directors or officers adopted
or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation
−Removed: Agreement and Plan of Merger, dated September 24, 2025, by and among Harrow, Inc., Harrow Acquisition Sub, Inc., Melt Pharmaceuticals, Inc., and D.
−Removed: Brad Osborne, as stockholder representative (“Merger Agreement”) (incorporated herein by reference to Exhibit 2.1 to the Current Report on Form 8-K of Harrow, Inc.
−Removed: filed with the Securities and Exchange Commission on October 1, 2025).
Amended and Restated Certificate of Incorporation, as amended (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K of Harrow, Inc.
filed with the Securities and Exchange Commission on September 29, 2023).
−Removed: Amended and Restated Bylaws of Harrow, Inc., dated as of August 21, 2025 (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K of Harrow, Inc.
+Added: Amended and Restated Bylaws of the Company, dated as of August 21, 2025 (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K of Harrow, Inc.
filed with the Securities and Exchange Commission on August 25, 2025).
−Removed: Indenture, dated September 12, 2025, by and among the Company, the guarantors named therein and U.S.
+Added: First Supplemental Indenture, dated as of March 27, 2026, by and between the Company, the guarantors named therein and U.S.
Bank Trust Company, National Association, as trustee (incorporated herein by reference to Exhibit 4.3 to the Current Report on Form 8-K of Harrow, Inc.
−Removed: filed with the Securities and Exchange Commission on September 12, 2025).
−Removed: Form of 8.625% Senior Note due 2030 (included in Exhibit 4.1).
−Removed: Offer Letter Agreement, dated as of August 15, 2025, by and between the Company and Randall E.
−Removed: Purchase Agreement, dated September 8, 2025, by and among the Company, the guarantors named therein and BTIG, LLC, as representative of the several initial purchasers named therein (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of Harrow, Inc.
−Removed: filed with the Securities and Exchange Commission on September 12, 2025).
−Removed: Milestone Payment Agreement, dated September 24, 2025, by and between Harrow, Inc.
−Removed: and Melt Pharmaceuticals, Inc.
−Removed: (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of Harrow, Inc.
−Removed: filed with the Securities and Exchange Commission on October 1, 2025).
−Removed: Commitment Letter, dated September 5, 2025, by and between the Company and Fifth Third Bank, National Association.
−Removed: Credit Agreement, dated as of September 26, 2025, by and among the Company, certain subsidiaries of the Company, as guarantors, the other lenders as may from time to time become parties thereunder, and Fifth Third Bank, National Association, as administrative agent for itself and the other lenders, the letter of credit issuer, the swing line lender, the sole lead arranger and the sole bookrunner.
+Added: filed with the Securities and Exchange Commission on March 27, 2026).
+Added: Form of 8.625% Senior Note due 2030 (included in Exhibit 4.1) (incorporated herein by reference to Exhibit 4.2 to the Current Report on Form 8-K of Harrow, Inc.
+Added: filed with the Securities and Exchange Commission on March 27, 2026).
+Added: Offer Letter dated January 30, 2026 by and between the Company and Patrick W.
+Added: Sullivan (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of Harrow, Inc.
+Added: filed with the Securities and Exchange Commission on February 2, 2026).
+Added: Consulting Agreement dated March 1, 2026 between Harrow, Inc.
+Added: Saharek (incorporated herein by reference to Exhibit 10.30 to the Annual Report on Form 10-K for the year ended December 31, 2025 of Harrow, Inc.
+Added: filed with the Securities and Exchange Commission on March 2, 2026).
+Added: Purchase Agreement, dated March 24, 2026, by and among the Company, the guarantors named therein and BTIG, LLC, as representative of the several initial purchasers named therein (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of Harrow, Inc.
+Added: filed with the Securities and Exchange Commission on March 27, 2026).
Certification of Mark L.
4 unchanged sentences
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Mark L.
−Removed: Baum, principal executive officer, Andrew R.
+Added: Baum, principal executive officer, and Andrew R.
Boll, principal financial officer.
6 unchanged sentences
XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, has been formatted in
+Added: cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, has been formatted in Inline
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
−Removed: November 10, 2025
Executive Officer and Director
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.